MetaCap

Who Owns CRISPR Therapeutics Stock?

NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.10+0.17 (+0.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
79.17%
Institutional holders
682
  • Institutions 79.2%
  • Insiders 6.0%
  • Public and other 14.8%

Who owns CRISPR Therapeutics stock?

Institutional investors own about 79.2% of CRISPR Therapeutics's shares, spread across 682 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.01% of CRSP.

The largest institutional holders are ARK Investment Management, LLC (10.37%), Blackrock Inc. (8.56%) and Orbis Allan Gray Ltd (5.62%). Together, the top 10 institutions control 46.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CRSP positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CRSP

CRISPR Therapeutics top institutional holders
InstitutionShares% HeldChange
ARK Investment Management, LLC10.06M10.37%+6.3%
Blackrock Inc.8.30M8.56%-0.6%
Orbis Allan Gray Ltd5.45M5.62%-10.8%
State Street Corporation4.99M5.15%+15.6%
Capital World Investors4.74M4.89%-0.2%
GSK plc2.61M2.69%-19.0%
Geode Capital Management, LLC2.51M2.59%+0.1%
T. Rowe Price Investment Management, Inc.2.05M2.12%-30.5%
SR One Capital Management, LP2.04M2.10%0.0%
Two Sigma Investments, LP1.99M2.05%+34.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CRSP

CRISPR Therapeutics top fund holders
FundShares% Held
ARK ETF Trust-ARK Innovation ETF5.38M5.55%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.72M2.80%
iShares Trust-iShares Russell 2000 ETF2.33M2.40%
ARK ETF Trust-ARK Genomic Revolution ETF2.28M2.35%
NEW PERSPECTIVE FUND1.94M2.00%
SmallCap World Fund Inc1.69M1.75%
Growth Fund of America1.41M1.46%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.11M1.14%
T. Rowe Price Mid-Cap Growth Fund, Inc.1.05M1.08%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.02M1.05%

Frequently asked questions

Who is the largest shareholder of CRISPR Therapeutics?

ARK Investment Management, LLC is the largest institutional shareholder of CRSP, owning 10.37% of shares outstanding (10.06M shares) as of its latest 13F filing.

What percentage of CRISPR Therapeutics is owned by institutions?

Institutions own about 79.2% of CRSP shares and 84.2% of the public float.

How much of CRISPR Therapeutics do insiders own?

Insiders, such as officers and directors, own about 6.01% of CRSP shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related